An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...

Weakening or rolling back longstanding environmental regulations would worsen the problem, the American Lung Association ...

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Engineer Denis Wirtz and colleagues are using artificial intelligence and multiscale imaging to reveal how tumors grow, ...

The Johns Hopkins Occupational Health team has launched a major upgrade to Cority, the software used to store and manage the ...

Researchers warn that cuts to federal science funding under Trump may jeopardize scientific progress, job security, and ...

This edition of Org Chart has news on a number of centers around campus, as well as a new endowed chair, a key financial ...

Sufferers say the pain caused by the nerve disorder is so debilitating that they can’t smile, laugh or even make eye contact with another person.

Without the support of NIH funding, some researchers fear their work could slow down or even stop in some labs.

UChicago Medicine is using a new technology to destroy liver tumors without radiation, chemotherapy or even cutting the skin.

In his inaugural address, President Daniel Coit Gilman, the University’s first president, made a statement on what he expects ...

Lowering blood pressure through medication can reduce someone's risk of developing dementia ...